AMGNAMGEN INC

Nasdaq amgen.com


$ 320.45 $ -3.80 (-1.17 %)    

Friday, 06-Sep-2024 15:59:41 EDT
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 320.56
$ 321.47 x 100
-- x --
-- - --
$ 242.41 - $ 344.45
2,242,451
na
172.25B
$ 0.53
$ 55.03
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-14-2024 12-31-2023 10-K
4 10-31-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 04-28-2023 03-31-2023 10-Q
7 02-09-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 04-28-2022 03-31-2022 10-Q
11 02-16-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 08-03-2021 06-30-2021 10-Q
14 04-28-2021 03-31-2021 10-Q
15 02-09-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 07-29-2020 06-30-2020 10-Q
18 05-01-2020 03-31-2020 10-Q
19 02-12-2020 12-31-2019 10-K
20 10-30-2019 09-30-2019 10-Q
21 07-31-2019 06-30-2019 10-Q
22 05-01-2019 03-31-2019 10-Q
23 02-13-2019 12-31-2018 10-K
24 10-31-2018 09-30-2018 10-Q
25 07-27-2018 06-30-2018 10-Q
26 04-25-2018 03-31-2018 10-Q
27 02-13-2018 12-31-2017 10-K
28 10-26-2017 09-30-2017 10-Q
29 07-26-2017 06-30-2017 10-Q
30 04-27-2017 03-31-2017 10-Q
31 02-14-2017 12-31-2016 10-K
32 10-28-2016 09-30-2016 10-Q
33 07-29-2016 06-30-2016 10-Q
34 05-02-2016 03-31-2016 10-Q
35 02-16-2016 12-31-2015 10-K
36 11-02-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
38 04-27-2015 03-31-2015 10-Q
39 02-19-2015 12-31-2014 10-K
40 10-29-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 fake-ozempic-targets-weight-loss-market-forged-batches-an-international-concern

Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation...

Core News & Articles

- Reuters 

 amgen-ceo-says-look-forward-to-obesity-drug-trial-data-showing-what-we-can-achieve-in-patients-that-are-obese--at-risk-of-heart-renal-liver-disease

- Morgan Stanley Conf

 despite-medicare-negotiations-americans-may-still-have-to-pay-more-for-prescription-drugs

Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly hig...

 intuit-amgen-and-sprott-uranium-miners-etf-cnbcs-final-trades

Jason Snipe of Odyssey Capital Advisors likes Intuit Inc., after the company beat on the top and bottom lines, but missed on gu...

 moodys-revises-amgens-outlook-to-stable-from-negative

- Reuters Citing Moody's Ratings

 us-stocks-may-take-a-breather-after-sp-500s-impressive-8-session-winning-streak-strategist-says-market-will-hit-fresh-highs-in-next-4-weeks-but-warns-investors-of-potential-risks

The gravity-defying climb faces risk, as the index futures trade narrowly mixed in early trading on Tuesday. That said, the rec...

 td-cowen-maintains-buy-on-amgen-raises-price-target-to-381

TD Cowen analyst Yaron Weber maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $360 to $381.

 amgens-mixed-q2-results-highlight-obesity-drug-potential-analysts-focus-shifts-to-upcoming-clinical-readouts

Amgen posted mixed Q2 results. Analysts highlight upcoming clinical readouts in obesity and inflammatory disease as crucial. De...

 oppenheimer-maintains-outperform-on-amgen-maintains-380-price-target

Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and maintains $380 price target.

 deutsche-bank-reiterates-hold-on-amgen-lowers-price-target-to-305

Deutsche Bank analyst James Shin reiterates Amgen (NASDAQ:AMGN) with a Hold and lowers the price target from $310 to $305.

 b-of-a-securities-maintains-neutral-on-amgen-raises-price-target-to-330

B of A Securities analyst Geoff Meacham maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $325 t...

 wall-street-poised-for-second-day-of-gains-while-bank-of-japan-makes-reassurances-dollar-strengthens-against-yen-crude-prices-surge-whats-driving-markets-wednesday

The U.S.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION